Olumacostat Glasaretil (DRM01) for the Treatment of Acne Vulgaris: Primary Results from the DRM01-ACN02 Phase 2b Randomized Controlled Trial

Authors

James Q. Del Rosso, Touro University NevadaFollow
Linda F. Stein GoldFollow
Leon Kircik
Jerry Tan
Catherine Maari
Robert Bissonnette
Hans Hofland

Document Type

Abstract

Publication Date

2017

Comments

See original material for complete list of authors.

Recommended Citation

Del Rosso, J. Q., Gold, L. F. S., Kircik, L., Tan, J., Maari, C., Bissonnette, R., . . . Webster, G. (2017). Olumacostat glasaretil (DRM01) for the treatment of acne vulgaris: Primary results from the DRM01-ACN02 phase 2b randomized controlled trial [Supplemental material]. Journal of Clinical and Aesthetic Dermatology, 10(5), S7.

Publisher's Statement

The original material can be found here: http://jcadonline.epubxp.com/i/824994-mauiderm-2017